Sandoz AG

Switzerland

Back to Profile

1-100 of 1,412 for Sandoz AG Sort by
Query
Aggregations
IP Type
        Trademark 1,038
        Patent 374
Jurisdiction
        World 660
        Europe 324
        United States 244
        Canada 184
Date
New (last 4 weeks) 1
2026 July 1
2026 June 9
2026 May 1
2026 April 2
See more
IPC Class
A61K 9/20 - Pills, lozenges or tablets 51
A61K 9/00 - Medicinal preparations characterised by special physical form 25
A61P 35/00 - Antineoplastic agents 24
A61K 9/16 - AgglomeratesGranulatesMicrobeadlets 21
A61K 9/14 - Particulate form, e.g. powders 12
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 955
10 - Medical apparatus and instruments 68
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 37
41 - Education, entertainment, sporting and cultural services 29
01 - Chemical and biological materials for industrial, scientific and agricultural use 23
See more
Status
Pending 35
Registered / In Force 1,377
  1     2     3     ...     15        Next Page

1.

JUZAVRIB

      
Application Number 019399048
Status Pending
Filing Date 2026-07-22
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

2.

SUDETLA

      
Serial Number 99905545
Status Pending
Filing Date 2026-06-25
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use

3.

CASUBDI

      
Serial Number 99905559
Status Pending
Filing Date 2026-06-25
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use

4.

NISVILUM

      
Serial Number 99905566
Status Pending
Filing Date 2026-06-25
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use

5.

IPSERVU

      
Serial Number 99905550
Status Pending
Filing Date 2026-06-25
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use

6.

IVAYU

      
Serial Number 99905554
Status Pending
Filing Date 2026-06-25
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use

7.

INSEMLI

      
Application Number 019381875
Status Pending
Filing Date 2026-06-17
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use, namely antidiabetics.

8.

ELGAVIDRA

      
Application Number 019379425
Status Pending
Filing Date 2026-06-11
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use, namely antidiabetics.

9.

SEMFYNLY

      
Application Number 1920187
Status Registered
Filing Date 2026-03-20
Registration Date 2026-03-20
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

10.

FYZDOBY

      
Application Number 1920191
Status Registered
Filing Date 2026-03-20
Registration Date 2026-03-20
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

11.

SEMLYDAQ

      
Application Number 1919002
Status Registered
Filing Date 2026-03-11
Registration Date 2026-03-11
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

12.

SEMROLBI

      
Application Number 1915400
Status Registered
Filing Date 2026-02-18
Registration Date 2026-02-18
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

13.

SEPVAZY

      
Application Number 1915409
Status Registered
Filing Date 2026-02-20
Registration Date 2026-02-20
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

14.

RULMAVI

      
Application Number 1915408
Status Registered
Filing Date 2026-02-20
Registration Date 2026-02-20
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

15.

WAVEHALER

      
Serial Number 99784492
Status Pending
Filing Date 2026-04-24
Owner Sandoz AG (Switzerland)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Inhalers for medical purposes, sold empty

16.

OWOZY

      
Application Number 1912378
Status Registered
Filing Date 2026-02-06
Registration Date 2026-02-06
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use, namely injectable pharmaceutical products for diabetes treatment.

17.

JORABTY

      
Application Number 019338860
Status Registered
Filing Date 2026-03-27
Registration Date 2026-07-16
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

pharmaceutical preparations for human use.

18.

YURZEMIQ

      
Application Number 019338861
Status Registered
Filing Date 2026-03-27
Registration Date 2026-07-16
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

pharmaceutical preparations for human use.

19.

ANQOLMY

      
Application Number 019338862
Status Registered
Filing Date 2026-03-27
Registration Date 2026-07-16
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

pharmaceutical preparations for human use.

20.

SAZEMFI

      
Application Number 019338919
Status Registered
Filing Date 2026-03-27
Registration Date 2026-07-16
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

pharmaceutical preparations for human use.

21.

OSLYMGI

      
Application Number 019338858
Status Registered
Filing Date 2026-03-27
Registration Date 2026-07-16
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

pharmaceutical preparations for human use.

22.

VIQSEMZO

      
Application Number 019338863
Status Registered
Filing Date 2026-03-27
Registration Date 2026-07-16
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

pharmaceutical preparations for human use.

23.

BENQUESS

      
Application Number 019338936
Status Registered
Filing Date 2026-03-27
Registration Date 2026-07-16
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

pharmaceutical preparations for human use.

24.

WAZEFY

      
Application Number 019338084
Status Registered
Filing Date 2026-03-26
Registration Date 2026-07-16
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

25.

FYZDOBY

      
Application Number 247948400
Status Pending
Filing Date 2026-03-20
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à savoir les infections du système nerveux central, les maladies du cerveau, les troubles du mouvement du système nerveux central, les troubles de la motilité oculaire, les maladies de la moelle épinière; préparations pharmaceutiques pour la prévention et le traitement de maladies immunologiques, à savoir des maladies auto-immunes, des syndromes de déficit immunitaire; préparations pharmaceutiques pour la prévention et le traitement des maladies cardiovasculaires; préparations pharmaceutiques pour la prévention et le traitement du diabète; préparations pharmaceutiques pour la prévention et le traitement des troubles métaboliques, à savoir le diabète, l'obésité, l'hyperlipidémie, la résistance à l'insuline, le syndrome métabolique; anti-inflammatoires; préparations pharmaceutiques pour la prévention et le traitement des troubles du système respiratoire; préparations pharmaceutiques pour la prévention et le traitement des troubles du système musculo-squelettique, à savoir les maladies du tissu conjonctif, les maladies des os, les maladies de la colonne vertébrale, les maux de dos, les fractures, les entorses, les blessures du cartilage; préparations pharmaceutiques pour la prévention et le traitement des maladies génito-urinaires, à savoir les maladies urologiques, l'infertilité, les maladies sexuellement transmissibles, les inflammations pelviennes; préparations pharmaceutiques utilisées en dermatologie, à savoir la dermatite, les maladies affectant la pigmentation de la peau, les maladies sexuellement transmissibles; préparations pharmaceutiques utilisées en oncologie; préparations pharmaceutiques utilisées en hématologie, à savoir pour le traitement des troubles sanguins; préparations pharmaceutiques utilisées pour la transplantation de tissus et d'organes; préparations pharmaceutiques utilisées en ophtalmologie; préparations pharmaceutiques utilisées en gastroentérologie; préparations pharmaceutiques pour la prévention et le traitement des troubles et des maladies oculaires; anti-infectieux, antibactériens, antiviraux, antibiotiques, antifongiques systémiques et topiques; tous les produits précités à usage humain.

26.

FYZDOBY

      
Serial Number 79451075
Status Pending
Filing Date 2026-03-20
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all the aforesaid goods for human use

27.

SEMFYNLY

      
Application Number 247948300
Status Pending
Filing Date 2026-03-20
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à savoir les infections du système nerveux central, les maladies du cerveau, les troubles du mouvement du système nerveux central, les troubles de la motilité oculaire, les maladies de la moelle épinière; préparations pharmaceutiques pour la prévention et le traitement de maladies immunologiques, à savoir des maladies auto-immunes, des syndromes de déficit immunitaire; préparations pharmaceutiques pour la prévention et le traitement des maladies cardiovasculaires; préparations pharmaceutiques pour la prévention et le traitement du diabète; préparations pharmaceutiques pour la prévention et le traitement des troubles métaboliques, à savoir le diabète, l'obésité, l'hyperlipidémie, la résistance à l'insuline, le syndrome métabolique; anti-inflammatoires; préparations pharmaceutiques pour la prévention et le traitement des troubles du système respiratoire; préparations pharmaceutiques pour la prévention et le traitement des troubles du système musculo-squelettique, à savoir les maladies du tissu conjonctif, les maladies des os, les maladies de la colonne vertébrale, les maux de dos, les fractures, les entorses, les blessures du cartilage; préparations pharmaceutiques pour la prévention et le traitement des maladies génito-urinaires, à savoir les maladies urologiques, l'infertilité, les maladies sexuellement transmissibles, les inflammations pelviennes; préparations pharmaceutiques utilisées en dermatologie, à savoir la dermatite, les maladies affectant la pigmentation de la peau, les maladies sexuellement transmissibles; préparations pharmaceutiques utilisées en oncologie; préparations pharmaceutiques utilisées en hématologie, à savoir pour le traitement des troubles sanguins; préparations pharmaceutiques utilisées pour la transplantation de tissus et d'organes; préparations pharmaceutiques utilisées en ophtalmologie; préparations pharmaceutiques utilisées en gastroentérologie; préparations pharmaceutiques pour la prévention et le traitement des troubles et des maladies oculaires; anti-infectieux, antibactériens, antiviraux, antibiotiques, antifongiques systémiques et topiques; tous les produits précités à usage humain.

28.

SEMFYNLY

      
Serial Number 79451072
Status Pending
Filing Date 2026-03-20
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all the aforesaid goods for human use

29.

SEMLYDAQ

      
Serial Number 79450592
Status Pending
Filing Date 2026-03-11
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

30.

SEMLYDAQ

      
Application Number 247801300
Status Pending
Filing Date 2026-03-11
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Préparations pharmaceutiques à usage humain pour la prévention et le traitement du système nerveux central, à savoir infections du système nerveux central, maladies cérébrales, troubles du mouvement du système nerveux central, troubles de la motilité oculaire, maladies de la moelle épinière; préparations pharmaceutiques à usage humain pour la prévention et le traitement de maladies immunologiques, à savoir maladies auto-immunes, syndromes d'immunodéficience; préparations pharmaceutiques à usage humain pour la prévention et le traitement des maladies cardiovasculaires; préparations pharmaceutiques à usage humain pour la prévention et le traitement de diabètes; préparations pharmaceutiques à usage humain pour la prévention et le traitement de troubles métaboliques, à savoir diabète, obésité, hyperlipidémie, résistance à l'insuline, syndrome métabolique; anti-inflammatoires à usage humain; préparations pharmaceutiques à usage humain pour la prévention et le traitement de troubles du système respiratoire; préparations pharmaceutiques à usage humain pour la prévention et le traitement de troubles du système musculo-squelettique, à savoir maladies du tissu conjonctif, maladies osseuses, maladies rachidiennes, douleurs dorsales, fractures, entorses, blessures cartilagineuses; préparations pharmaceutiques à usage humain pour la prévention et le traitement de maladies génito- urinaires, à savoir maladies urologiques, infertilité, maladies sexuellement transmissibles, maladies pelviennes inflammatoires; préparations pharmaceutiques à usage humain à utiliser en dermatologie, à savoir pour les dermatites, les maladies de pigmentation de la peau, les maladies sexuellement transmissibles; préparations pharmaceutiques à usage humain utilisées en oncologie; préparations pharmaceutiques à usage humain à utiliser en hématologie, à savoir pour le traitement de troubles sanguins; préparations pharmaceutiques à usage humain utilisées dans le cadre de la transplantation d'organes et de tissus; préparations pharmaceutiques à usage humain utilisées en ophtalmologie; préparations pharmaceutiques à usage humain utilisées en gastro-entérologie; préparations pharmaceutiques à usage humain pour la prévention et le traitement de troubles et maladies oculaires; anti-infectieux à usage humain, antibactériens à usage humain, antiviraux à usage humain, antibiotiques à usage humain, antifongiques systémiques et topiques à usage humain.

31.

RULMAVI

      
Application Number 247280200
Status Pending
Filing Date 2026-02-20
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Préparations pharmaceutiques à usage humain pour la prévention et le traitement du système nerveux central, à savoir les infections du système nerveux central, les maladies du cerveau, les troubles du mouvement du système nerveux central, les troubles de la motilité oculaire, les maladies de la moelle épinière; préparations pharmaceutiques à usage humain pour la prévention et le traitement de maladies immunologiques, à savoir des maladies auto-immunes, des syndromes de déficit immunitaire; préparations pharmaceutiques à usage humain pour la prévention et le traitement des maladies cardiovasculaires; préparations pharmaceutiques à usage humain pour la prévention et le traitement du diabète; préparations pharmaceutiques à usage humain pour la prévention et le traitement des troubles métaboliques, à savoir le diabète, l'obésité, l'hyperlipidémie, la résistance à l'insuline, le syndrome métabolique; anti-inflammatoires à usage humain; préparations pharmaceutiques à usage humain pour la prévention et le traitement des troubles du système respiratoire; préparations pharmaceutiques à usage humain pour la prévention et le traitement des troubles du système musculo-squelettique, à savoir les maladies du tissu conjonctif, les maladies des os, les maladies de la colonne vertébrale, les maux de dos, les fractures, les entorses, les blessures du cartilage; préparations pharmaceutiques à usage humain pour la prévention et le traitement des maladies génito-urinaires, à savoir les maladies urologiques, l'infertilité, les maladies sexuellement transmissibles, les inflammations pelviennes; préparations pharmaceutiques à usage humain utilisées en dermatologie, à savoir la dermatite, les maladies affectant la pigmentation de la peau, les maladies sexuellement transmissibles; préparations pharmaceutiques à usage humain utilisées en oncologie; préparations pharmaceutiques à usage humain utilisées en hématologie, à savoir pour le traitement des troubles sanguins; préparations pharmaceutiques à usage humain utilisée pour la transplantation de tissus et d'organes; préparations pharmaceutiques à usage humain utilisées en ophtalmologie; préparations pharmaceutiques à usage humain utilisées en gastroentérologie; préparations pharmaceutiques à usage humain pour la prévention et le traitement des troubles et des maladies oculaires; anti-infectieux à usage humain, antibactériens à usage humain, antiviraux à usage humain, antibiotiques à usage humain, antifongiques systémiques et topiques à usage humain.

32.

SEPVAZY

      
Application Number 247280100
Status Pending
Filing Date 2026-02-20
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Préparations pharmaceutiques à usage humain pour la prévention et le traitement du système nerveux central, à savoir les infections du système nerveux central, les maladies du cerveau, les troubles du mouvement du système nerveux central, les troubles de la motilité oculaire, les maladies de la moelle épinière; préparations pharmaceutiques à usage humain pour la prévention et le traitement de maladies immunologiques, à savoir des maladies auto-immunes, des syndromes de déficit immunitaire; préparations pharmaceutiques à usage humain pour la prévention et le traitement des maladies cardiovasculaires; préparations pharmaceutiques à usage humain pour la prévention et le traitement du diabète; préparations pharmaceutiques à usage humain pour la prévention et le traitement des troubles métaboliques, à savoir le diabète, l'obésité, l'hyperlipidémie, la résistance à l'insuline, le syndrome métabolique; anti-inflammatoires à usage humain; préparations pharmaceutiques à usage humain pour la prévention et le traitement des troubles du système respiratoire; préparations pharmaceutiques à usage humain pour la prévention et le traitement des troubles du système musculo-squelettique, à savoir les maladies du tissu conjonctif, les maladies des os, les maladies de la colonne vertébrale, les maux de dos, les fractures, les entorses, les blessures du cartilage; préparations pharmaceutiques à usage humain pour la prévention et le traitement des maladies génito-urinaires, à savoir les maladies urologiques, l'infertilité, les maladies sexuellement transmissibles, les inflammations pelviennes; préparations pharmaceutiques à usage humain utilisées en dermatologie, à savoir la dermatite, les maladies affectant la pigmentation de la peau, les maladies sexuellement transmissibles; préparations pharmaceutiques à usage humain utilisées en oncologie; préparations pharmaceutiques à usage humain utilisées en hématologie, à savoir pour le traitement des troubles sanguins; préparations pharmaceutiques à usage humain utilisée pour la transplantation de tissus et d'organes; préparations pharmaceutiques à usage humain utilisées en ophtalmologie; préparations pharmaceutiques à usage humain utilisées en gastroentérologie; préparations pharmaceutiques à usage humain pour la prévention et le traitement des troubles et des maladies oculaires; anti-infectieux à usage humain, antibactériens à usage humain, antiviraux à usage humain, antibiotiques à usage humain, antifongiques systémiques et topiques à usage humain.

33.

OMNICLICK

      
Application Number 019320050
Status Registered
Filing Date 2026-02-20
Registration Date 2026-06-05
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

injection device for pharmaceuticals.

34.

RULMAVI

      
Serial Number 79449018
Status Pending
Filing Date 2026-02-20
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Anti-infectives for human use; anti-inflammatories for human use; antibacterial pharmaceutical preparations for human use; antibiotics for human use; antifungal preparations for human use; antivirals for human use; cardiovascular pharmaceutical preparations for human use; dermatological pharmaceutical preparations for human use; pharmaceutical preparations for human use for inhaling for prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for human use acting on the central nervous system; pharmaceutical preparations and substances for human use for prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for human use for prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for human use in hematology and in tissue and organ transplantation; pharmaceutical preparations for human use for prevention and treatment of eye diseases; pharmaceutical preparations for human use for prevention and treatment of heart rhythm disorders; pharmaceutical preparations for human use for prevention and treatment of diseases and disorders related to the immune system; pharmaceutical preparations for human use for prevention and treatment of kidney diseases; pharmaceutical preparations for human use for prevention and treatment of diabetes; pharmaceutical preparations for human use for prevention and treatment of hypertension; pharmaceutical preparations for human use for prevention and treatment of skin conditions; pharmaceutical preparations for human use in dermatology; pharmaceutical preparations for human use in urology; pharmaceutical preparations for human use in ophthalmology; pharmaceutical preparations for human use for prevention and treatment of cancer and tumors; pharmaceutical preparations for human use for prevention and treatment of allergies; pharmaceutical preparations for human use for prevention and treatment of bone diseases; pharmaceutical preparations for human use for prevention and treatment of respiratory diseases and asthma

35.

SEPVAZY

      
Serial Number 79449019
Status Pending
Filing Date 2026-02-20
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Anti-infectives for human use; anti-inflammatories for human use; antibacterial pharmaceutical preparations for human use; antibiotics for human use; antifungal preparations for human use; antivirals for human use; cardiovascular pharmaceutical preparations for human use; dermatological pharmaceutical preparations for human use; pharmaceutical preparations for human use for inhaling for prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for human use acting on the central nervous system; pharmaceutical preparations and substances for human use for prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for human use for prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for human use in hematology and in tissue and organ transplantation; pharmaceutical preparations for human use for prevention and treatment of eye diseases; pharmaceutical preparations for human use for prevention and treatment of heart rhythm disorders; pharmaceutical preparations for human use for prevention and treatment of diseases and disorders related to the immune system; pharmaceutical preparations for human use for prevention and treatment of kidney diseases; pharmaceutical preparations for human use for prevention and treatment of diabetes; pharmaceutical preparations for human use for prevention and treatment of hypertension; pharmaceutical preparations for human use for prevention and treatment of skin conditions; pharmaceutical preparations for human use in dermatology; pharmaceutical preparations for human use in urology; pharmaceutical preparations for human use in ophthalmology; pharmaceutical preparations for human use for prevention and treatment of cancer and tumors; pharmaceutical preparations for human use for prevention and treatment of allergies; pharmaceutical preparations for human use for prevention and treatment of bone diseases; pharmaceutical preparations for human use for prevention and treatment of respiratory diseases and asthma.

36.

OPTIMATE

      
Serial Number 99660477
Status Pending
Filing Date 2026-02-19
Owner Sandoz AG (Switzerland)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Injection device for pharmaceuticals

37.

SEMROLBI

      
Serial Number 79449015
Status Pending
Filing Date 2026-02-18
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all the aforesaid goods for human use

38.

SEMROLBI

      
Application Number 247279600
Status Pending
Filing Date 2026-02-18
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à savoir les infections du système nerveux central, les maladies du cerveau, les troubles du mouvement du système nerveux central, les troubles de la motilité oculaire, les maladies de la moelle épinière; préparations pharmaceutiques pour la prévention et le traitement de maladies immunologiques, à savoir des maladies auto-immunes, des syndromes de déficit immunitaire; préparations pharmaceutiques pour la prévention et le traitement des maladies cardiovasculaires; préparations pharmaceutiques pour la prévention et le traitement du diabète; préparations pharmaceutiques pour la prévention et le traitement des troubles métaboliques, à savoir le diabète, l'obésité, l'hyperlipidémie, la résistance à l'insuline, le syndrome métabolique; anti-inflammatoires; préparations pharmaceutiques pour la prévention et le traitement des troubles du système respiratoire; préparations pharmaceutiques pour la prévention et le traitement des troubles du système musculo-squelettique, à savoir les maladies du tissu conjonctif, les maladies des os, les maladies de la colonne vertébrale, les maux de dos, les fractures, les entorses, les blessures du cartilage; préparations pharmaceutiques pour la prévention et le traitement des maladies génito-urinaires, à savoir les maladies urologiques, l'infertilité, les maladies sexuellement transmissibles, les inflammations pelviennes; préparations pharmaceutiques utilisées en dermatologie, à savoir la dermatite, les maladies affectant la pigmentation de la peau, les maladies sexuellement transmissibles; préparations pharmaceutiques utilisées en oncologie; préparations pharmaceutiques utilisées en hématologie, à savoir pour le traitement des troubles sanguins; préparations pharmaceutiques utilisée pour la transplantation de tissus et d'organes; préparations pharmaceutiques utilisées en ophtalmologie; préparations pharmaceutiques utilisées en gastroentérologie; préparations pharmaceutiques pour la prévention et le traitement des troubles et des maladies oculaires; anti-infectieux, antibactériens, antiviraux, antibiotiques, antifongiques systémiques et topiques; tous les produits précités à usage humain.

39.

OWOZY

      
Application Number 246784800
Status Pending
Filing Date 2026-02-06
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Préparations pharmaceutiques à usage humain, à savoir produits pharmaceutiques injectables pour le traitement du diabète.

40.

OWOZY

      
Serial Number 79447824
Status Pending
Filing Date 2026-02-06
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use, namely, injectable pharmaceutical preparations for treatment of diabetes

41.

PRE-FILLED SYRINGE CONTAINING AVACINCAPTAD FORMULATION

      
Application Number EP2025072117
Publication Number 2026/027707
Status In Force
Filing Date 2025-07-31
Publication Date 2026-02-05
Owner SANDOZ AG (Switzerland)
Inventor
  • Homar, Miha
  • Naversnik, Klemen

Abstract

Avacincaptad pegol, also known under the trademarks Izervay or Zimura, is a molecule comprising an aptamer sequence and a polyethylene glycol polymer (PEG) -moiety. The aptamer sequence binds to complement C5-protein, which C5 protein is known to be involved in many eye diseases. Avacincaptad pegol is approved to treat Age-related Macular Degeneration (AMD) secondary to Geographic Atrophy (GA) and is applied by intravitreal injection into the eye. The pharmaceutical product is currently only offered as a liquid in a vial. This patent application discloses Avacincaptad in a more stable presentation, namely in a pre-filled syringe, which surprisingly results in very significantly improved stability of the product.

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 9/08 - Solutions
  • A61K 31/711 - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
  • A61K 47/02 - Inorganic compounds
  • C12N 15/115 - Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith

42.

AVUESS

      
Application Number 1890850
Status Registered
Filing Date 2025-10-15
Registration Date 2025-10-15
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical products.

43.

INHALER DEVICE

      
Application Number 18720337
Status Pending
Filing Date 2022-12-13
First Publication Date 2025-10-23
Owner Sandoz AG (Switzerland)
Inventor
  • Tibbatts, James Anthony
  • Cocker, Robin Craig
  • Popa, Cristian
  • Mutti, Paul Christopher Edward
  • Borrett, Robert
  • Goodchild, Kesia

Abstract

The present invention relates to an inhaler device for use with an elongate strip medicament carrier comprising a base with a plurality of medicament pockets or blisters and a peelable lidding sheet covering the blisters, the inhaler device comprising; an indexer movable in a first direction to advance a blister pocket into an inhalation position; an opening system for peeling the peelable lidding sheet from the base to expose medicament within each medicament pocket; the opening system comprising a peel management component movable in a first direction corresponding to said first direction of the indexer to delay the peeling action when the indexer is advanced, and in a second, opposite, direction to allow the lidding sheet to be peeled from the base; wherein the indexer and peel management component are separately driven in said first direction so that movement of the indexer does not dictate movement of the peel management component.

IPC Classes  ?

44.

Miscellaneous Design

      
Serial Number 79437092
Status Pending
Filing Date 2025-10-21
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Anti-infectives for human use; anti-inflammatories for human use; antibacterial pharmaceutical preparations for human use; antibiotics for human use; antifungal preparations for human use; antivirals for human use; cardiovascular pharmaceutical preparations for human use; dermatological pharmaceutical preparations for human use; pharmaceutical preparations for human use for inhaling for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for human use acting on the central nervous system; pharmaceutical preparations and substances for human use for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for human use for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for human use, used in hematology and in tissue and organ transplantation; pharmaceutical preparations for human use for the prevention and treatment of eye diseases; pharmaceutical preparations for human use for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for human use for the prevention and treatment of diseases and disorders related to the immune system; pharmaceutical preparations for human use for the prevention and treatment of kidney diseases; pharmaceutical preparations for human use for the prevention and treatment of diabetes; pharmaceutical preparations for human use for the prevention and treatment of hypertension; pharmaceutical preparations for human use for the prevention and treatment of skin conditions; pharmaceutical preparations for human use, used in dermatology; pharmaceutical preparations for human use, used in urology; pharmaceutical preparations for human use, used in ophthalmology; pharmaceutical preparations for human use for the prevention and treatment of cancer and tumors; pharmaceutical preparations for human use for the prevention and treatment of allergies; pharmaceutical preparations for human use for the prevention and treatment of bone diseases; pharmaceutical preparations for human use for the prevention and treatment of respiratory diseases and asthma

45.

PAFLEMOR

      
Application Number 019262843
Status Registered
Filing Date 2025-10-17
Registration Date 2026-01-30
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

46.

FLIZDEO

      
Application Number 019262875
Status Registered
Filing Date 2025-10-17
Registration Date 2026-01-30
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

47.

DAZGAFLIM

      
Application Number 019261414
Status Registered
Filing Date 2025-10-15
Registration Date 2026-01-30
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

48.

Miscellaneous Design

      
Application Number 019254893
Status Registered
Filing Date 2025-10-01
Registration Date 2026-01-22
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

pharmaceutical preparations for human use.

49.

Drug delivery device

      
Application Number 29944128
Grant Number D1088218
Status In Force
Filing Date 2024-05-25
First Publication Date 2025-08-12
Grant Date 2025-08-12
Owner Sandoz AG (Switzerland)
Inventor Rizner, Leon

50.

Drug delivery device

      
Application Number 29944127
Grant Number D1087326
Status In Force
Filing Date 2024-05-25
First Publication Date 2025-08-05
Grant Date 2025-08-05
Owner Sandoz AG (Switzerland)
Inventor Rizner, Leon

51.

NELVIZI

      
Application Number 019223280
Status Registered
Filing Date 2025-07-24
Registration Date 2025-11-07
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

52.

Packaging

      
Application Number 29865821
Grant Number D1083620
Status In Force
Filing Date 2022-08-15
First Publication Date 2025-07-15
Grant Date 2025-07-15
Owner Sandoz AG (Switzerland)
Inventor Frerichs, Ilse

53.

CRYSTALLINE FORMS OF ELACESTRANT DIHYDROCHLORIDE

      
Application Number EP2024087830
Publication Number 2025/133072
Status In Force
Filing Date 2024-12-20
Publication Date 2025-06-26
Owner SANDOZ AG (Switzerland)
Inventor
  • Lengauer, Hannes
  • Margreiter, Renate
  • Pichler, Arthur

Abstract

The present invention relates to novel crystalline forms of Elacestrant dihydrochloride. The present invention also relates to a pharmaceutical composition comprising the crystalline forms of Elacestrant dihydrochloride of the present invention, as well of methods of using the same in the treatment of conditions and diseases driven by estrogen, preferably for the treatment of breast cancer.

IPC Classes  ?

  • C07C 217/84 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
  • A61P 35/00 - Antineoplastic agents

54.

BEVPAZMI

      
Application Number 240720100
Status Pending
Filing Date 2025-06-24
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals.

55.

YESVIJO

      
Application Number 1850614
Status Registered
Filing Date 2025-01-28
Registration Date 2025-01-28
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

56.

COCRYSTALS OF VORASIDENIB

      
Application Number EP2024078644
Publication Number 2025/078570
Status In Force
Filing Date 2024-10-11
Publication Date 2025-04-17
Owner SANDOZ AG (Switzerland)
Inventor
  • Stefinovic, Marijan
  • Griesser, Ulrich
  • Gelbrich, Thomas
  • Primorac, Kristina
  • Braun, Doris

Abstract

The present invention relates to vorasidenib solid-state forms, to a pharmaceutical composition comprising them, and to processes for their preparation.

IPC Classes  ?

  • C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
  • C07C 57/15 - Fumaric acid
  • C07C 59/255 - Tartaric acid
  • A61P 35/00 - Antineoplastic agents
  • A61K 31/53 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

57.

MEYLEDBA

      
Application Number 019172614
Status Registered
Filing Date 2025-04-14
Registration Date 2025-07-26
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

58.

STIBNAXAB

      
Application Number 019172664
Status Registered
Filing Date 2025-04-14
Registration Date 2025-07-26
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

59.

SUDELBREN

      
Application Number 019172667
Status Registered
Filing Date 2025-04-14
Registration Date 2025-07-26
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

60.

LUVABDEQ

      
Application Number 019172611
Status Registered
Filing Date 2025-04-14
Registration Date 2025-07-31
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

61.

ODUBINLIV

      
Application Number 019172624
Status Registered
Filing Date 2025-04-14
Registration Date 2025-07-31
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

62.

DIVREBZI

      
Application Number 019172644
Status Registered
Filing Date 2025-04-14
Registration Date 2025-07-31
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

63.

TUMAGNAR

      
Application Number 019172652
Status Registered
Filing Date 2025-04-14
Registration Date 2025-07-26
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

64.

KEVTIZLA

      
Application Number 019172653
Status Registered
Filing Date 2025-04-14
Registration Date 2025-07-26
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

65.

CAVZYDLI

      
Application Number 019172663
Status Registered
Filing Date 2025-04-14
Registration Date 2025-07-26
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

66.

DUYOMZAB

      
Application Number 019172669
Status Registered
Filing Date 2025-04-14
Registration Date 2025-07-26
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

67.

LINEX

      
Application Number 019171548
Status Registered
Filing Date 2025-04-11
Registration Date 2025-08-24
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use, namely biotics; food supplements.

68.

KEPGAZO

      
Application Number 1846672
Status Registered
Filing Date 2025-01-28
Registration Date 2025-01-28
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

69.

JUMABYR

      
Application Number 1846674
Status Registered
Filing Date 2025-01-28
Registration Date 2025-01-28
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

70.

PASVILDA

      
Application Number 1846673
Status Registered
Filing Date 2025-01-28
Registration Date 2025-01-28
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

71.

Inhaler

      
Application Number 29842609
Grant Number D1067421
Status In Force
Filing Date 2022-06-14
First Publication Date 2025-03-18
Grant Date 2025-03-18
Owner SANDOZ AG (Switzerland)
Inventor
  • Evans, Tim
  • Chhabildas, Vinnay

72.

CRYSTALLINE FORMS OF TAPINAROF

      
Application Number EP2024071848
Publication Number 2025/031935
Status In Force
Filing Date 2024-08-01
Publication Date 2025-02-13
Owner SANDOZ AG (Switzerland)
Inventor
  • Lengauer, Hannes
  • Margreiter, Renate
  • Pichler, Arthur

Abstract

The present invention relates to Tapinarof dimethylacetamide solvate and crystalline forms thereof, processes for preparation and pharmaceutical compositions thereof. Furthermore, the invention concerns its use for the preparation of a medicament, preferably for the treatment of skin diseases.

IPC Classes  ?

  • C07C 39/21 - Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic part, with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
  • C07C 233/05 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
  • A61K 31/05 - Phenols
  • A61P 17/06 - Antipsoriatics

73.

DAGZITOG

      
Application Number 019139723
Status Registered
Filing Date 2025-02-06
Registration Date 2025-05-23
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

74.

FILZADAP

      
Application Number 019139815
Status Registered
Filing Date 2025-02-06
Registration Date 2025-05-23
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

75.

RIZEGMEF

      
Application Number 019139759
Status Registered
Filing Date 2025-02-06
Registration Date 2025-05-23
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

76.

CABRENVA

      
Application Number 019139789
Status Registered
Filing Date 2025-02-06
Registration Date 2025-05-23
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment of multiple sclerosis.

77.

DAGLOZVIQ

      
Application Number 019139835
Status Registered
Filing Date 2025-02-06
Registration Date 2025-05-23
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

78.

TORNETIS

      
Application Number 019137362
Status Registered
Filing Date 2025-01-30
Registration Date 2025-06-07
Owner SANDOZ AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations, namely antihypertonic preparations as well as urologic preparations.

79.

PASVILDA

      
Serial Number 79420232
Status Registered
Filing Date 2025-01-28
Registration Date 2025-10-07
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

80.

KEPGAZO

      
Serial Number 79420231
Status Registered
Filing Date 2025-01-28
Registration Date 2025-10-07
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.

81.

JUMABYR

      
Serial Number 79420233
Status Registered
Filing Date 2025-01-28
Registration Date 2025-10-07
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

82.

YESVIJO

      
Serial Number 79421975
Status Registered
Filing Date 2025-01-28
Registration Date 2025-10-07
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

83.

Drug delivery device

      
Application Number 29944129
Grant Number D1057937
Status In Force
Filing Date 2024-05-25
First Publication Date 2025-01-14
Grant Date 2025-01-14
Owner Sandoz AG (Switzerland)
Inventor Rizner, Leon

84.

ENAXARBA

      
Application Number 019122484
Status Registered
Filing Date 2024-12-19
Registration Date 2025-04-17
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

85.

CLYCELPA

      
Application Number 019122500
Status Registered
Filing Date 2024-12-19
Registration Date 2025-04-17
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

86.

PAXFYDOS

      
Application Number 019122517
Status Registered
Filing Date 2024-12-19
Registration Date 2025-05-03
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

87.

Process for the preparation of sucrose octasulfate octakistriethylammonium salt (TASOS) powder and uses thereof

      
Application Number 18704233
Status Pending
Filing Date 2022-10-25
First Publication Date 2024-12-19
Owner Sandoz AG (Switzerland)
Inventor Zupancic, Borut

Abstract

The present invention refers to a process for preparing sucrose octasulfate octakistriethylammonium salt (TASOS) powder, comprising the steps of combining a TASOS solution with a polar organic solvent(s) and triethylamine, thereby obtaining a TASOS solution, the polar organic solvent(s), and triethylamine; concentrating said TASOS solution; combining it with 2-methyltetrahydrofuran and/or tetrahydrofuran and triethylamine, thereby obtaining a mixture; and stirring said mixture until a white TASOS powder is obtained. The present invention refers to a process for preparing sucrose octasulfate octakistriethylammonium salt (TASOS) powder, comprising the steps of combining a TASOS solution with a polar organic solvent(s) and triethylamine, thereby obtaining a TASOS solution, the polar organic solvent(s), and triethylamine; concentrating said TASOS solution; combining it with 2-methyltetrahydrofuran and/or tetrahydrofuran and triethylamine, thereby obtaining a mixture; and stirring said mixture until a white TASOS powder is obtained. The present invention also refers to a sucrose octasulfate octakistriethylammonium salt (TASOS) powder having a purity of at least 96%, the use of the sucrose octasulfate octakistriethylammonium salt (TASOS) powder for preparing a pharmaceutical composition, and the use of tetrahydrofuran or 2-methyltetrahydrofuran as antisolvent for the preparation of TASOS powder. The present invention refers to a process for preparing sucrose octasulfate octakistriethylammonium salt (TASOS) powder, comprising the steps of combining a TASOS solution with a polar organic solvent(s) and triethylamine, thereby obtaining a TASOS solution, the polar organic solvent(s), and triethylamine; concentrating said TASOS solution; combining it with 2-methyltetrahydrofuran and/or tetrahydrofuran and triethylamine, thereby obtaining a mixture; and stirring said mixture until a white TASOS powder is obtained. The present invention also refers to a sucrose octasulfate octakistriethylammonium salt (TASOS) powder having a purity of at least 96%, the use of the sucrose octasulfate octakistriethylammonium salt (TASOS) powder for preparing a pharmaceutical composition, and the use of tetrahydrofuran or 2-methyltetrahydrofuran as antisolvent for the preparation of TASOS powder. Finally, the present invention refers to a pharmaceutical composition prepared by using the sucrose octasulfate octakistriethylammonium salt (TASOS) powder of the present invention, and to the pharmaceutical composition for use in treating cancer.

IPC Classes  ?

  • C07H 11/00 - Compounds containing saccharide radicals esterified by inorganic acidsMetal salts thereof
  • A61K 31/7024 - Esters of saccharides
  • C07H 1/06 - SeparationPurification

88.

ZUHIRIO

      
Application Number 019122369
Status Registered
Filing Date 2024-12-19
Registration Date 2025-04-17
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

89.

BREKDIPA

      
Application Number 019122537
Status Registered
Filing Date 2024-12-19
Registration Date 2025-04-17
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

90.

Miscellaneous Design

      
Application Number 1821771
Status Registered
Filing Date 2024-08-06
Registration Date 2024-08-06
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

91.

Miscellaneous Design

      
Application Number 1818092
Status Registered
Filing Date 2024-07-24
Registration Date 2024-07-24
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

92.

SOLID-STATE FORMS OF 2-(3-(4-(1H-INDAZOL-5-YLAMINO)QUINAZOLIN-2-YL)PHENOXY)-N-ISOPROPYLACETAMIDE METHANE SULFONIC ACID SALT

      
Application Number 18579041
Status Pending
Filing Date 2022-07-18
First Publication Date 2024-10-17
Owner Sandoz AG (Switzerland)
Inventor
  • Lengauer, Hannes
  • Margreiter, Renate
  • Pichler, Arthur

Abstract

The present invention relates to solid-state forms of 2-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide methane sulfonic acid (INN: belumosudil mesylate) and processes for their preparation. Furthermore, the invention relates to a pharmaceutical composition comprising a solid-state form of the present invention and at least one pharmaceutically acceptable excipient. The pharmaceutical composition of the present invention can be used as a medicament, in particular for the treatment and/or prophylaxis of autoimmune diseases such as graft-versus-host disease (GvHD) and systemic sclerosis.

IPC Classes  ?

  • C07D 403/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
  • A61K 9/28 - DrageesCoated pills or tablets
  • A61K 31/517 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

93.

ERELZI

      
Serial Number 79411104
Status Registered
Filing Date 2024-10-15
Registration Date 2025-10-28
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

94.

MANDELATE FORM OF 1-(4-(((6-AMINO-5-(4-PHENOXYPHENYL)PYRIMIDIN-4-YL)AMINO)METHYL)PIPERIDIN-1-YL)PROP-2-EN-1-ONE

      
Application Number 18578864
Status Pending
Filing Date 2022-07-15
First Publication Date 2024-10-03
Owner Sandoz AG (Switzerland)
Inventor
  • Lengauer, Hannes
  • Margreiter, Renate
  • Pichler, Arthur

Abstract

The present invention relates to a mandelate form of 1-(4-(((6-amino-5-(4-phenoxyphenyl) pyrimidin-4-yl)amino)methyl)piperidin-1-yl)prop-2-en-1-one (INN: evobrutinib) and a process of producing the same. Furthermore, the invention relates to a pharmaceutical composition comprising the mandelate form of evobrutinib and at least one pharmaceutically acceptable excipient. The pharmaceutical composition of the present invention can be used as a medicament, in particular for the treatment and/or prevention of multiple sclerosis.

IPC Classes  ?

  • C07D 401/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
  • A61K 31/506 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
  • C07C 59/50 - Mandelic acid

95.

STABLE COMPOSITION COMPRISING A HIGH PROTEIN CONCENTRATION

      
Application Number EP2023058394
Publication Number 2024/199665
Status In Force
Filing Date 2023-03-30
Publication Date 2024-10-03
Owner SANDOZ AG (Switzerland)
Inventor
  • Zula, Ales
  • Zidar, Mitja
  • Pavsic, Jernej

Abstract

The present invention relates to aqueous high protein concentration compositions, particularly pharmaceutical compositions. The pharmaceutical compositions are useful for delivery of high concentration of the protein active ingredient, such as an antibody, to a patient without high levels of protein aggregation, or other destabilizing factors. The compositions of the invention comprise about 100 mg/mL or more of protein.

IPC Classes  ?

  • A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
  • A61P 11/06 - Antiasthmatics
  • A61P 17/00 - Drugs for dermatological disorders
  • A61P 27/14 - Decongestants or antiallergics
  • C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

96.

Drug delivery device

      
Application Number 29926405
Grant Number D1042795
Status In Force
Filing Date 2024-01-30
First Publication Date 2024-09-17
Grant Date 2024-09-17
Owner Sandoz AG (Switzerland)
Inventor Rizner, Leon

97.

Crystalline Form of Sotorasib

      
Application Number 18571039
Status Pending
Filing Date 2022-06-23
First Publication Date 2024-08-29
Owner Sandoz AG (Switzerland)
Inventor
  • Adamer, Verena
  • Margreiter, Renate
  • Pichler, Arthur

Abstract

The present invention relates to a crystalline form of sotorasib and to a process for its preparation. Furthermore, the invention relates to a pharmaceutical composition comprising the crystalline form of sotorasib of the present invention and at least one pharmaceutically acceptable excipient. The pharmaceutical composition of the present invention can be used as a medicament, in particular for the treatment of a cancer with a KRAS mutation.

IPC Classes  ?

  • C07D 471/04 - Ortho-condensed systems
  • A61K 9/20 - Pills, lozenges or tablets
  • A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

98.

bleu et vert sphère

      
Application Number 236191500
Status Pending
Filing Date 2024-08-06
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Préparations pharmaceutiques à usage humain pour la prévention et le traitement du système nerveux central, à savoir infections du système nerveux central, maladies cérébrales, troubles du mouvement du système nerveux central, troubles de la motilité oculaire, maladies de la moelle épinière; préparations pharmaceutiques à usage humain pour la prévention et le traitement de maladies immunologiques, à savoir maladies auto-immunes, syndromes d'immunodéficience; préparations pharmaceutiques à usage humain pour la prévention et le traitement des maladies cardiovasculaires; préparations pharmaceutiques à usage humain pour la prévention et le traitement de diabètes; préparations pharmaceutiques à usage humain pour la prévention et le traitement de troubles métaboliques, à savoir diabète, obésité, hyperlipidémie, résistance à l'insuline, syndrome métabolique; anti-inflammatoires à usage humain; préparations pharmaceutiques à usage humain pour la prévention et le traitement de troubles du système respiratoire; préparations pharmaceutiques à usage humain pour la prévention et le traitement de troubles du système musculo squelettique, à savoir maladies du tissu conjonctif, maladies osseuses, maladies rachidiennes, douleurs dorsales, fractures, entorses, blessures cartilagineuses; préparations pharmaceutiques à usage humain pour la prévention et le traitement de maladies génito-urinaires, à savoir maladies urologiques, infertilité, maladies sexuellement transmissibles, maladies pelviennes inflammatoires; préparations pharmaceutiques à usage humain à utiliser en dermatologie, à savoir pour les dermatites, les maladies de pigmentation de la peau, les maladies sexuellement transmissibles; préparations pharmaceutiques à usage humain utilisées en oncologie; préparations pharmaceutiques à usage humain à utiliser en hématologie, à savoir pour le traitement de troubles sanguins; préparations pharmaceutiques à usage humain utilisées dans le cadre de la transplantation d'organes et de tissus; préparations pharmaceutiques à usage humain utilisées en ophtalmologie; préparations pharmaceutiques à usage humain utilisées en gastro-entérologie; préparations pharmaceutiques à usage humain pour la prévention et le traitement de troubles et maladies oculaires; anti infectieux à usage humain, antibactériens à usage humain, antiviraux à usage humain, antibiotiques à usage humain, antifongiques systémiques et topiques à usage humain.

99.

AFZEF

      
Application Number 234102300
Status Registered
Filing Date 2024-07-29
Registration Date 2025-07-04
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders

100.

EXLUSYTE

      
Application Number 234104800
Status Registered
Filing Date 2024-07-29
Registration Date 2025-07-04
Owner Sandoz AG (Switzerland)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders
  1     2     3     ...     15        Next Page